Clot Care Images
DVT Awareness | Join Our Email List | Thursday, September 09, 2010

Postings on Intracranial Vascular Disease

For Patients and Caregivers

Posting Date Posted
Leading authority challenges the safety and efficacy of carotid artery stents compared to carotid endarterectomy November, 2007
FDA Approves Robotic Arm to Help Stroke Patients Recover Use of Arms July, 2007

Frequently Asked Questions Date Posted
Where can I find an anticoagulation expert near my home or office? October, 2005

For Health Care Providers

Posting Date Posted
ProFESS gives new direction for selection of antiplatelet therapies for stroke patients November, 2008
Carotid Artery Disease: Routine Screening for CAD is NOT Recommended February, 2008
Do "statins" increase the risk of hemorrhagic stroke? February, 2008
Leading authority challenges the safety and efficacy of carotid artery stents compared to carotid endarterectomy November, 2007
FDA Approves Robotic Arm to Help Stroke Patients Recover Use of Arms July, 2007
Aspirin Resistance: Do we have standardized methods for measurement? September, 2005
"Mini Strokes" with Maximum Impact August, 2005
Combination antiplatelet therapy for stroke patients at high risk of recurrence May, 2005
New Data on Aspirin vs. Warfarin in TIA Patients, but Questions Persist March, 2005
Is Warfarin-Induced Bleeding Increasing? August, 2004

Frequently Asked Questions Date Posted
Where can I find an anticoagulation expert near my home or office? October, 2005
Copyright 2000-2010 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to webmaster@clotcare.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.